Literature DB >> 18706762

Placebo response in neuropathic pain trials.

Steve N Quessy1, Michael C Rowbotham.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18706762     DOI： 10.1016/j.pain.2008.06.024

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  30 in total

1.  Assay sensitivity and study features in neuropathic pain trials: an ACTTION meta-analysis.

Authors:  Robert H Dworkin; Dennis C Turk; Sarah Peirce-Sandner; Hua He; Michael P McDermott; John T Farrar; Nathaniel P Katz; Allison H Lin; Bob A Rappaport; Michael C Rowbotham
Journal:  Neurology       Date:  2013-05-22       Impact factor: 9.910

Review 2.  The placebo response in medicine: minimize, maximize or personalize?

Authors:  Paul Enck; Ulrike Bingel; Manfred Schedlowski; Winfried Rief
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

Review 3.  The placebo response: relationship to outcomes in trials of postherpetic neuralgia.

Authors:  Gordon Irving
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.

Authors:  Mark S Wallace; Gordon Irving; Verne E Cowles
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

Review 5.  Pharmacological management of central post-stroke pain: a practical guide.

Authors:  Jong S Kim
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 5.749

6.  Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy.

Authors:  Mitra Tavakoli; Omar Asghar; Uazman Alam; Ioannis N Petropoulos; Hassan Fadavi; Rayaz A Malik
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

Review 7.  Design and conduct of confirmatory chronic pain clinical trials.

Authors:  Nathaniel Katz
Journal:  Pain Rep       Date:  2020-12-18

Review 8.  An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis.

Authors:  Akio Arakawa; Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859

9.  Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.

Authors:  Dan Ziegler; Lusine Movsesyan; Boris Mankovsky; Irina Gurieva; Zhangentkhan Abylaiuly; Igor Strokov
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

10.  Efficacy and safety of lacosamide in painful diabetic neuropathy.

Authors:  Dan Ziegler; Tibor Hidvégi; Irina Gurieva; Sabine Bongardt; Rainer Freynhagen; David Sen; Kenneth Sommerville
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.